| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOPHA.2008.01.010 |
| P698 | PubMed publication ID | 18358680 |
| P50 | author | Valentina Ambrosini | Q37842637 |
| P2093 | author name string | Paolo Castellucci | |
| Cristina Nanni | |||
| Domenico Rubello | |||
| Gaia Grassetto | |||
| Paola Tomassetti | |||
| Giancarlo Montini | |||
| Stefano Fanti | |||
| Roberto Franchi | |||
| Vincenzo Allegri | |||
| P433 | issue | 10 | |
| P304 | page(s) | 667-671 | |
| P577 | publication date | 2008-03-03 | |
| P1433 | published in | Biomedicine and Pharmacotherapy | Q15759648 |
| P1476 | title | Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET. | |
| P478 | volume | 62 |
| Q53283178 | 68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®). |
| Q26849276 | Clinical applications of Gallium-68 |
| Q37482780 | Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma |
| Q33870879 | Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease |
| Q46911836 | Could 68Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas? |
| Q36467722 | EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma |
| Q34645505 | Gastroenteropancreatic neuroendocrine tumour arising in Meckel's diverticulum coexisting with colon adenocarcinoma. |
| Q48089118 | Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA. |
| Q38563625 | Imaging in neuroendocrine tumors: an update for the clinician |
| Q37633402 | Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues |
| Q92335045 | Long-Term Follow-Up of a Patient with Primary Presacral Neuroendocrine Tumor: A Case Report with Literature Review |
| Q90494655 | MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies |
| Q38038842 | Newer imaging techniques in head and neck cancer |
| Q59074896 | PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors |
| Q26992201 | PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature |
| Q34410500 | Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment |
| Q42993036 | Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. |
| Q49897007 | The Role of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography in Well-Differentiated Neuroendocrine Tumors: A Case-Based Approach Illustrates Potential Benefits and Challenges |
| Q37541215 | Von Hippel-Lindau syndrome: demonstration of entire disease spectrum with (68)Ga-DOTANOC PET-CT. |
| Q37990397 | ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. |
| Q37990398 | ⁶⁸Ga-labelled peptides in the management of neuroectodermal tumours |
Search more.